title: Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study.
abstract: BACKGROUND
  Oral contraceptive (OC) use increases the risk of venous thromboembolism (VTE), but the effect of duration of use remains to be elucidated.
  
  
  METHODS
  This case-control study was aimed to investigate the duration of OC use on the risk of VTE according to women age, periods of use, prevalence of other risk factors and the role of thrombophilia abnormalities. Seven-hundred patients and 209 controls who used OC were stratified into short users (≤1year), long users (1 to 5years), and very long users (>5years).
  
  
  CONCLUSIONS
  Compared to non-users, the odds ratio (OR) for VTE was 9.0 (95% CI 6.9-12.2) in short, 6.5 (95% CI 4.8-83.7) in long and 5.9 (95% CI 4.4-8.1) in very long users. The risk of VTE in short users was highest in women ≤30years and in the first year of use (OR 13.1, 95% CI 7.7-22.4) and decreased afterward (OR 7.7, 95% CI 5.0-11.9). This trend was not observed in women >30years. Compared to non-carriers and non-users, a joint effect of thrombophilia abnormalities and OC use on VTE risk was observed particularly in short users (OR 62.2, 95% CI 29.8-129.6), but also afterward (OR 25.4, 95% CI 16.5-39.2). Other transient risk factors for VTE were present in 25% of very long and 16% of short users. In conclusion, the risk of VTE in OC users decreases over time only before 30years and in first users. Thrombophilia abnormalities strongly interact with the duration of OC use in determining VTE.
authors.affiliation: A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: martin@policlinico.mi.it.
authors.forename: Ida
authors.initials: I
authors.lastname: Martinelli
authors.affiliation: A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: alberto.maino@gmail.com.
authors.forename: Alberto
authors.initials: A
authors.lastname: Maino
authors.affiliation: A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: maria.abba88@gmail.com.
authors.forename: Maria
authors.initials: M
authors.lastname: Abbattista
authors.affiliation: A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: bucciarelli@policlinico.mi.it.
authors.forename: Paolo
authors.initials: P
authors.lastname: Bucciarelli
authors.affiliation: A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: seremap@gmail.com.
authors.forename: Serena M
authors.initials: SM
authors.lastname: Passamonti
authors.affiliation: A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: andrea.artoni@policlinico.mi.it.
authors.forename: Andrea
authors.initials: A
authors.lastname: Artoni
authors.affiliation: A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: franiello@libero.it.
authors.forename: Francesca
authors.initials: F
authors.lastname: Gianniello
authors.affiliation: A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: flora.peyvandi@unimi.it.
authors.forename: Flora
authors.initials: F
authors.lastname: Peyvandi
mesh_terms: D000293:Adolescent; D000328:Adult; D016022:Case-Control Studies; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D016017:Odds Ratio; D012307:Risk Factors; D019851:Thrombophilia / Q000150:complications; D054556:Venous Thromboembolism / Q000139:chemically induced* / Q000453:epidemiology; D055815:Young Adult
chemical_list: D003276:Contraceptives, Oral
keywords: Oral contraceptives; Risk factors; Thrombophilia; Venous thrombosis; Women's health